Immunotherapy by Immune Checkpoint Inhibitors and Nuclear Medicine Imaging: Current and Future Applications
Immunotherapy by using immune checkpoint inhibitors is a revolutionary development in oncology. Medical imaging is also impacted by this new therapy, particularly nuclear medicine imaging (also called radionuclide imaging), which uses radioactive tracers to visualize metabolic functions. Our aim was...
Main Authors: | Pierre Decazes, Pierre Bohn |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2020-02-01
|
Series: | Cancers |
Subjects: | |
Online Access: | https://www.mdpi.com/2072-6694/12/2/371 |
Similar Items
-
Progress of PET Imaging Agents for Cardiovascular Diseases
by: MA Hui1;LIANG Hong1;XU Wan-bang2;TANG Gang-hua1
Published: (2018-04-01) -
Molecular Targeted Positron Emission Tomography Imaging and Radionuclide Therapy of Pancreatic Ductal Adenocarcinoma
by: Thomas T. Poels, et al.
Published: (2021-12-01) -
[<sup>18</sup>F]Fluorothymidine Uptake in the Porcine Pancreatic Elastase-Induced Model of Abdominal Aortic Aneurysm
by: Richa Gandhi, et al.
Published: (2021-08-01) -
Sex-Related Differences in Metastatic Melanoma Patients Treated with Immune Checkpoint Inhibition
by: Ken Kudura, et al.
Published: (2022-10-01) -
Inflammatory Blood Parameters as Biomarkers for Response to Immune Checkpoint Inhibition in Metastatic Melanoma Patients
by: Ken Kudura, et al.
Published: (2022-08-01)